Optical detection of the structural properties of tumor tissue generated by xenografting of drug-sensitive and drug-resistant cancer cells using partial wave spectroscopy (PWS).

A mesoscopic physics-based optical imaging technique, partial wave spectroscopy (PWS), has been used for the detection of cancer by probing nanoscale structural alterations in cells/tissue. The development of drug-resistant cancer cells/tissues during chemotherapy is a major challenge in cancer treatment. In this paper, using a mouse model and PWS, the structural properties of tumor tissue grown in 3D structures by xenografting drug-resistant and drug-sensitive human prostate cancer cells having 2D structures, are studied. The results show that the 3D xenografted tissues maintain a similar hierarchy of the degree of structural disorder properties as that of the 2D original drug-sensitive and drug-resistant cells.

[1]  P. Pradhan,et al.  Light localization properties of weakly disordered optical media using confocal microscopy: application to cancer detection. , 2017, Optics express.

[2]  F. Liu,et al.  New mouse xenograft model modulated by tumor-associated fibroblasts for human multi-drug resistance in cancer , 2015, Oncology reports.

[3]  Aris Persidis,et al.  Cancer multidrug resistance , 1999, Nature Biotechnology.

[4]  A. Yagoda,et al.  Cytotoxic chemotherapy for advanced hormone‐resistant prostate cancer , 1993, Cancer.

[5]  J. Nickerson,et al.  Nuclear dreams: The malignant alteration of nuclear architecture , 1998, Journal of cellular biochemistry.

[6]  A. Aref,et al.  Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance , 2019, Molecular Cancer.

[7]  J. Machiels,et al.  Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial , 2010, The Lancet.

[8]  Peter J Houghton,et al.  Establishment of human tumor xenografts in immunodeficient mice , 2007, Nature Protocols.

[9]  Allen Taflove,et al.  Quantification of nanoscale density fluctuations by electron microscopy: probing cellular alterations in early carcinogenesis , 2011, Physical biology.

[10]  Allen Taflove,et al.  Optical methodology for detecting histologically unapparent nanoscale consequences of genetic alterations in biological cells , 2008, Proceedings of the National Academy of Sciences.

[11]  Vadim Backman,et al.  Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy. , 2009, Cancer research.

[12]  Daniele Zink,et al.  Nuclear structure in cancer cells , 2004, Nature Reviews Cancer.

[13]  J. D. de Bono,et al.  Treatment of Advanced Prostate Cancer-A Review of Current Therapies and Future Promise. , 2018, Cold Spring Harbor perspectives in medicine.

[14]  M. Jaggi,et al.  Quantification of photonic localization properties of targeted nuclear mass density variations: Application in cancer‐stage detection , 2018, Journal of biophotonics.

[15]  Subhas C. Kundu,et al.  Sequential release of drugs from hollow manganese ferrite nanocarriers for breast cancer therapy. , 2015, Journal of materials chemistry. B.

[16]  Allen Taflove,et al.  Quantification of nanoscale density fluctuations using electron microscopy: Light-localization properties of biological cells. , 2010, Applied physics letters.

[17]  Vadim Backman,et al.  Association between rectal optical signatures and colonic neoplasia: potential applications for screening. , 2009, Cancer research.

[18]  B. Konety,et al.  Nuclear structural proteins as biomarkers of cancer , 1999, Journal of cellular biochemistry.

[19]  T. Yang,et al.  Insights into Chemoresistance of Prostate Cancer , 2015, International journal of biological sciences.

[20]  V. Backman,et al.  Partial-wave microscopic spectroscopy detects subwavelength refractive index fluctuations: an application to cancer diagnosis. , 2009, Optics letters.

[21]  Vadim Backman,et al.  Role of cytoskeleton in controlling the disorder strength of cellular nanoscale architecture. , 2010, Biophysical journal.

[22]  Murali M. Yallapu,et al.  Optical study of chemotherapy efficiency in cancer treatment via intracellular structural disorder analysis using partial wave spectroscopy , 2017, Journal of biophotonics.

[23]  M. Michael,et al.  Tumoral drug metabolism: overview and its implications for cancer therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Sarah A Heerboth,et al.  Drug Resistance in Cancer: An Overview , 2014, Cancers.

[25]  D. Osoba,et al.  Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Shikhar Uttam,et al.  Nanoscale nuclear architecture for cancer diagnosis beyond pathology via spatial-domain low-coherence quantitative phase microscopy. , 2010, Journal of biomedical optics.

[27]  W. V. van Weerden,et al.  Use of nude mouse xenograft models in prostate cancer research , 2000, The Prostate.

[28]  Jean-Pierre Gillet,et al.  Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance , 2011, Proceedings of the National Academy of Sciences.